Abstract:OBJECTIVE:Hepatocellular carcinoma (HCC) is the most common type of primary liver cancer in adults with a high rate of malignancy. The potent invasion and migration of HCC mainly impact the prognosis and recurrence of the disease. Our previous study found that miR-99b was highly expressed in HCC, and its expression was associated with vascular invasion. It was speculated that miR-99b may play a role in HCC invasion and migration, while the specific mechanism remains unclear.MATERIALS AND METHODS:qRT-PCR was applied to detect expressions of miR-99b and KAI1 genes in L02, HepG2, and MHCC97H cells. HepG2 cells were transfected with miR-99b inhibitor, miR-99b mimic, and NC. Flow cytometry was used to test cell cycle and apoptosis. Dual-luciferase reporter gene assay was adopted to validate the target gene of miR-99b. Wound healing assay was used to detect cell migration. Transwell assay was performed to detect cell invasion. Western blot was performed to detect KAI1, E-cadherin, and N-cadherin expressions. Immunofluorescence assay was adopted to test Vimentin expression.RESULTS:The level of miR-99b was reduced in L02 while up-regulated in MHCC97H. By contrast, the expression of KAI1 was increased in L02 but declined in MHCC97H. The transfection of miR-99b mimic inhibited HepG2 apoptosis and accelerated cell cycle. MiR-99b suppressed KAI gene expression through targeting its 3'-UTR. MiR-99b mimic or si-KAI1 transfection promoted cell invasion and migration, while their simultaneous action significantly enhanced cell invasion and migration. The overexpression of miR-99b or knockdown of KAI1 significantly weakened HepG2 cell adhesion, reduced E-cadherin expression, upregulated N-cadherin and Vimentin, and promoted cell epithelial-mesenchymal transition (EMT).CONCLUSIONS:MiR-99b contributes to promoting function in HCC migration and invasion through inhibiting KAI1 expression.

Mir-9 Inhibits the Metastatic Ability of Hepatocellular Carcinoma Via Targeting Beta Galactoside Alpha-2,6-sialyltransferase 1

The Role of Mir-99B in Mediating Hepatocellular Carcinoma Invasion and Migration.

Mir-192, A Prognostic Indicator, Targets the Slc39a6/Snail Pathway to Reduce Tumor Metastasis in Human Hepatocellular Carcinoma

Mir-424-3p Promotes Metastasis of Hepatocellular Carcinoma Via Targeting the SRF-STAT1/2 Axis.

Mir-194 is A Marker of Hepatic Epithelial Cells and Suppresses Metastasis of Liver Cancer Cells in Mice

Comprehensive Profiling of Novel Microrna-9 Targets and a Tumor Suppressor Role of Microrna-9 Via Targeting IGF2BP1 in Hepatocellular Carcinoma

Mir-200A Suppresses Cell Growth and Migration by Targeting MACC1 and Predicts Prognosis in Hepatocellular Carcinoma.

Mir-139-5p Inhibits Aerobic Glycolysis, Cell Proliferation, Migration, and Invasion in Hepatocellular Carcinoma Via a Reciprocal Regulatory Interaction with ETS1

MiR-199a-5p and let-7c cooperatively inhibit migration and invasion by targeting MAP4K3 in hepatocellular carcinoma.

MiR-34a Inhibits Lymphatic Metastasis Potential of Mouse Hepatoma Cells

Mir-142-3p Inhibits the Metastasis of Hepatocellular Carcinoma Cells by Regulating HMGB1 Gene Expression.

Mir-17-5p and Mir-20A-5p Suppress Postoperative Metastasis of Hepatocellular Carcinoma Via Blocking HGF/ERBB3-NF-κB Positive Feedback Loop

Mir-9 and Mir-181A Target Gab2 to Inhibit the Proliferation and Migration of Hepatocellular Carcinoma HepG2 Cells

Mir-187-3p Inhibits the Metastasis and Epithelial-Mesenchymal Transition of Hepatocellular Carcinoma by Targeting S100A4.

MicroRNA-140-5p suppresses tumor growth and metastasis by targeting transforming growth factor β receptor 1 and fibroblast growth factor 9 in hepatocellular carcinoma.

Mir-876 Inhibits EMT and Liver Fibrosis Via POSTN to Suppress Metastasis in Hepatocellular Carcinoma

MicroRNA-24-1 Suppresses Mouse Hepatoma Cell Invasion and Metastasis Via Directly Targeting O -Glcnac Transferase

Overexpressed Mir-9 Promotes Tumor Metastasis Via Targeting E-cadherin in Serous Ovarian Cancer

Let-7c Inhibits Metastatic Ability of Mouse Hepatocarcinoma Cells Via Targeting Mannoside Acetylglucosaminyltransferase 4 Isoenzyme A.

ST6GAL1 inhibits metastasis of hepatocellular carcinoma via modulating sialylation of MCAM on cell surface

Loss of N-Acetylgalactosaminyltransferase-4 Orchestrates Oncogenic MicroRNA-9 in Hepatocellular Carcinoma